The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 04, 2006

Filed:

Sep. 24, 2002
Applicants:

Roger A. Smith, Madison, CT (US);

Stephen J. O'connor, Guilford, CT (US);

Wai C. Wong, Trumbull, CT (US);

Soongyu Choi, Skillman, NJ (US);

Harold C. Kluender, Trumbull, CT (US);

Jianmei Fan, Hamden, CT (US);

Zhonghua Zhang, Derby, CT (US);

Rico C. Lavoie, Chesire, CT (US);

Brent L. Podlogar, Flemington, NJ (US);

Inventors:

Roger A. Smith, Madison, CT (US);

Stephen J. O'Connor, Guilford, CT (US);

Wai C. Wong, Trumbull, CT (US);

Soongyu Choi, Skillman, NJ (US);

Harold C. Kluender, Trumbull, CT (US);

Jianmei Fan, Hamden, CT (US);

Zhonghua Zhang, Derby, CT (US);

Rico C. Lavoie, Chesire, CT (US);

Brent L. Podlogar, Flemington, NJ (US);

Assignee:

Bayer Pharmaceuticals Corporation, West Haven, CT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/40 (2006.01); A61K 31/395 (2006.01); A61K 31/437 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention relates to 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.


Find Patent Forward Citations

Quick Actions:

Smith, Roger. (2006). Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity (U.S. Patent No. 7071207). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7071207

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…